EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy

Mariana Gospodinova, Elena Kinova, Iana Simova, Yoto Yotov, Marina Garcheva, Galina Kirova, Kamelia Genova, Albena Todorova, Stayko Sarafov, Ivailo Tournev, Mariya Tokmakova, Vasil Velchev

Bulgarian Cardiology · 2020

DOI: 10.3897/bgcardio.26.e53407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulgarian Cardiology, 2020. Verfasst von Mariana Gospodinova und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transthyretin cardiac amyloidosis is a restrictive cardiomyopathy ((ATTR-CM), caused by an extracellular deposition of insoluble amyloid fibrils in the myocardium. It is a life threatening disease with life expectancy of 2 to 6 years after diagnosis. There are two types – hereditary and wild type. Recent data reveal that the wild type ATTR-CM is a common cause of heart failure with preserved ejection fraction, especially in elderly men. Hereditary ATTR amyloidosis is not so rare in Bulgaria. Five different mutations have been diagnosed, the most common being p.Glu89Gln, identified in 62 unrelated families with 117 patients and 72 mutation carriers. ATTR-CM diagnosis is often delayed or even missed, however its early recognition has become very important as a new drug, which is a transthyretin stabilizer is now available and other drugs are under development. Updated knowledge about the clinical presentation, diagnostic algorithm, available and future therapeutic options for ATTR-CM are a prerequisite for an early identification, timely treatment and better prognosis of the affected patients. The diagnosis requires a multidisciplinary approach with the participation of experienced specialists, multimodality imaging, well equipped histopathological and genetic laboratories. Establishing centres of expertise could improve the management of the patients with ATTR-CM.

Zitieren

APA

Gospodinova, M., Kinova, E., Simova, I., Yotov, Y., Garcheva, M., Kirova, G., Genova, K., Todorova, A., Sarafov, S., Tournev, I., Tokmakova, M., & Velchev, V. (2020). Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy. Bulgarian Cardiology. https://doi.org/10.3897/bgcardio.26.e53407

Vancouver

Gospodinova M, Kinova E, Simova I, Yotov Y, Garcheva M, Kirova G, et al. Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy. Bulgarian Cardiology. 2020. doi:10.3897/bgcardio.26.e53407

BibTeX
@article{Gospodinova2020,
  author = {Gospodinova, Mariana and Kinova, Elena and Simova, Iana and Yotov, Yoto and Garcheva, Marina and Kirova, Galina and Genova, Kamelia and Todorova, Albena and Sarafov, Stayko and Tournev, Ivailo and Tokmakova, Mariya and Velchev, Vasil},
  title = {Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy},
  journal = {Bulgarian Cardiology},
  year = {2020},
  doi = {10.3897/bgcardio.26.e53407}
}
Kostenlos starten →